Moderna Stock Rises 3% On Vertex Deal
BioNTech Buys German Site From Novartis To Boost Covid-19 Vaccine Supply
Covid-19 roundup: Trump questions Redfield after hearing remarks; Oxford suggests side effect not caused by vaccine
Sorrento Pops 28% On FDA Nod To Kick Off Covid-19 Antibody Trial
Illumina Eyes Grail Acquisition For Over $8B – Report
Gilead Sciences: Don’t Underestimate This Pharma Giant’s Growth Potential, Says Analyst
Vaxart Can Still Be a Major Force in the COVID-19 Vaccine Landscape, Says Analyst
Morgan Stanley Bets on These 3 Stocks; Sees Over 40% Upside
Concerns Mount – FDA May Approve Deadly Vaccine
Bill Gates embroiled in controversy over coronavirus vaccine safety
NIH Raises Concerns About Potential Safety Issues Associated with AstraZeneca Vaccine
Former FDA Executive on COVID-19 and Convalescent Plasma
News briefing: Top FDA official exits; Sun Genomics closes $9.25M Series A
Abbott Starts Shipping 15-Minute Covid-19 Test After FDA Emergency Use Nod
Why AstraZeneca and others racing to make a COVID-19 vaccine should be more open about the process
Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy
Covid-19 Vaccine Makers’ Pledge May Not Quell Uprising
Penumbra Inc.’s Catheter Fail: Broken Tips and Lost Lives
NIH ‘very concerned’ about serious side effect in AstraZeneca's PhIII Covid-19 trial
Oppenheimer: 3 Stocks That Could Surge Over 100% From Current Levels
Bill Gates Slams FDA, Doubts Agency Can Be Trusted With COVID-19 Vaccine
AstraZeneca’s Pivotal Covid-19 Vaccine Trial Kept On Hold In US- Report
Marinus Spikes 63% On Positive Phase 3 Trial For Rare Genetic Epilepsy
US Close – All about M&A today, Stopgap likely, OPEC+ to stay the course, Gold shines, Biden Momentum
Cool eyes on fever screening: Optimizing infrared thermography
Moderna or BioNTech: J.P. Morgan Lays Odds On the Race to a COVID-19 Vaccine
Monday’s Market Snapshot: Here’s What You Need To Know Right Now
Dynavax Scores Supply Deal For Valneva’s Covid-19 Vaccine; Street Bullish
These 3 Penny Stocks Could Double (Or More), Says BTIG
Futures Surge On Monday Merger Mania, Fresh Vaccine Hopes